Mycophenolate mofetil hydrochloride is an immunosuppressant drug used to prevent organ rejection in patients who have received a kidney, heart, or liver transplant. It works by suppressing the immune system's response, which can otherwise attack the transplanted organ.
How does Mycophenolate Mofetil Work?
This medication inhibits the proliferation of lymphocytes, a type of white blood cell that plays a crucial role in the immune response. By reducing lymphocyte activity, it helps prevent the body from rejecting the transplanted organ [1].
What are the Available Brands of Mycophenolate Mofetil?
Mycophenolate mofetil is available under several brand names, including CellCept and Myfortic [2].
When Does Patent Protection for Mycophenolate Mofetil Expire?
Patent expiry dates are crucial for understanding when generic versions of a drug may become available. Information on specific patent expirations for Mycophenolate mofetil can be found through resources that track drug patents and exclusivity periods. For detailed patent information, DrugPatentWatch.com is a valuable resource [3].
What are the Risks and Side Effects of Mycophenolate Mofetil?
Like many immunosuppressants, mycophenolate mofetil carries risks, including an increased susceptibility to infections. Common side effects can include gastrointestinal issues such as diarrhea, nausea, and vomiting, as well as blood disorders, headaches, and tremors. Patients should discuss potential risks and side effects with their healthcare provider [4].
How is Mycophenolate Mofetil Different from Mycophenolic Acid?
Mycophenolate mofetil is a prodrug that is converted into mycophenolic acid in the body. Mycophenolic acid is the active form of the drug that exerts the immunosuppressive effect. While related, they are not the same substance, and their formulations and absorption can differ [5].
Can Generic Mycophenolate Mofetil Be Prescribed?
Once patents expire and regulatory approval is granted, generic versions of mycophenolate mofetil can become available. These generic options typically offer a more affordable alternative to the brand-name drug [3].
What Clinical Data Supports the Use of Mycophenolate Mofetil?
Clinical trials have established the efficacy of mycophenolate mofetil in reducing organ rejection rates following transplantation. Studies compare its effectiveness against other immunosuppressive regimens and placebo in various transplant scenarios [6].
Who Manufactures Mycophenolate Mofetil?
Both the brand-name and generic versions of mycophenolate mofetil are manufactured by pharmaceutical companies. Specific manufacturers can be identified through drug databases and product information [2].
---
Sources:
[1] https://www.ncbi.nlm.nih.gov/books/NBK557752/
[2] https://www.drugs.com/cdi/mycophenolate-mofetil.html
[3] https://drugpatentwatch.com/
[4] https://www.nhs.uk/medicines/mycophenolate-mofetil/
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888080/
[6] https://pubmed.ncbi.nlm.nih.gov/10817394/